Datroway FDA Approval for First-Line Metastatic TNBC
Review the FDA approval of Datroway (datopotamab deruxtecan) for first-line metastatic TNBC. Analyze TROPION-Breast02 efficacy, survival, and safety data.
Back to Articles
Articles tagged with “datopotamab-deruxtecan”